TY - JOUR
T1 - Changes in the societal burden caused by sleep apnoea in Finland from 1996 to 2018
T2 - A national registry study
AU - Mattila, Tiina
AU - Hasala, Hannele
AU - Kreivi, Hanna Riikka
AU - Avellan-Hietanen, Heidi
AU - Bachour, Adel
AU - Herse, Fredrik
AU - Leskelä, Riikka Leena
AU - Toppila-Salmi, Sanna
AU - Erhola, Marina
AU - Haahtela, Tari
AU - Vasankari, Tuula
N1 - Funding Information:
The corresponding author Tiina Mattila performed this study with financial support from the Hospital District of Helsinki and Uusimaa. All other co-authors conducted the work related to this study as part of their regular duties. Sanna Toppila-Salmi has got grants (GSK) and consultancy fees (ALK Abello, AstraZeneca, ERT, Novartis, Sanofi Pharma, Roche Products) outside of this work. Tari Haahtela has got lecture fees (GSK, Mundipharma, Orion Pharma, Sanofi) outside of this work. The corresponding author and the other authors do not have any relevant conflicts of interest.
Funding Information:
The Finnish Institute for Health and Welfare funded collection of the data. Financial support from the Hospital District of Helsinki and Uusimaa awarded to the first author allowed data analysis and preparation of the manuscript. Additionally, we acknowledge chief doctor Hanna Tapanainen from Hyvink?? Hospital for CPAP data from Hyvink?? Hospital. The data analysed in this study are not directly available to others. Anybody may apply for a study permit and access to the data from the appropriate registers from Findata and from the relevant hospital districts. Other related documents, including memos and plans for this study (mainly in Finnish), will be available 2 years after publication for researchers upon reasonable request ([email protected]).
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/5
Y1 - 2022/5
N2 - Background: In the current century, sleep apnoea has become a significant public health problem due to the obesity epidemic. To increase awareness, improve diagnostics, and improve treatment, Finland implemented a national sleep apnoea programme from 2002 to 2010. Here, we present changes in the societal burden caused by sleep apnoea from 1996 to 2018. Methods: National register data were collected from the Care Register for Health Care, Statistics Finland, the Social Insurance Institution of Finland, and the Finnish Centre for Pensions. Disease prevalence, use of healthcare and social services, and societal costs were estimated. Findings: The number of sleep apnoea patients increased in secondary care from 8 600 in 1996 to 61 000 in 2018. There was a continuous increase in outpatient visits in secondary care from 9 700 in 1996 to 122 000 in 2018 (1 160%) and in primary care from 10 000 in 2015 to 29 000 in 2018 (190%). Accordingly, the cumulative annual number of days off work for sleep apnoea increased from 1 100 to 46 000. However, disability pensions for sleep apnoea decreased from 820 to 550 (33%) during the observation period. Societal costs per patient decreased over 50% during the observation period (€2 800 to €1 200). Interpretation: The number of sleep apnoea patients in Finland increased remarkably during the observation period. To control this burden, diagnostic methods and treatment were revised and follow up was reorganised. Consequently, there was a significant decrease in societal costs per patient. The decrease in disability pensions suggests earlier diagnosis and improved treatment. The national sleep apnoea programme was one of the initiators for these improved outcomes. Funding: The Finnish Institute for Health and Welfare and the Hospital District of Helsinki and Uusimaa (HUH), Helsinki, Finland.
AB - Background: In the current century, sleep apnoea has become a significant public health problem due to the obesity epidemic. To increase awareness, improve diagnostics, and improve treatment, Finland implemented a national sleep apnoea programme from 2002 to 2010. Here, we present changes in the societal burden caused by sleep apnoea from 1996 to 2018. Methods: National register data were collected from the Care Register for Health Care, Statistics Finland, the Social Insurance Institution of Finland, and the Finnish Centre for Pensions. Disease prevalence, use of healthcare and social services, and societal costs were estimated. Findings: The number of sleep apnoea patients increased in secondary care from 8 600 in 1996 to 61 000 in 2018. There was a continuous increase in outpatient visits in secondary care from 9 700 in 1996 to 122 000 in 2018 (1 160%) and in primary care from 10 000 in 2015 to 29 000 in 2018 (190%). Accordingly, the cumulative annual number of days off work for sleep apnoea increased from 1 100 to 46 000. However, disability pensions for sleep apnoea decreased from 820 to 550 (33%) during the observation period. Societal costs per patient decreased over 50% during the observation period (€2 800 to €1 200). Interpretation: The number of sleep apnoea patients in Finland increased remarkably during the observation period. To control this burden, diagnostic methods and treatment were revised and follow up was reorganised. Consequently, there was a significant decrease in societal costs per patient. The decrease in disability pensions suggests earlier diagnosis and improved treatment. The national sleep apnoea programme was one of the initiators for these improved outcomes. Funding: The Finnish Institute for Health and Welfare and the Hospital District of Helsinki and Uusimaa (HUH), Helsinki, Finland.
KW - Obesity
KW - Public health
KW - Respiratory programme
KW - Sleep apnoea
U2 - 10.1016/j.lanepe.2022.100338
DO - 10.1016/j.lanepe.2022.100338
M3 - Article
AN - SCOPUS:85125396018
SN - 2666-7762
VL - 16
JO - The Lancet Regional Health - Europe
JF - The Lancet Regional Health - Europe
M1 - 100338
ER -